BLR&D Research Career Scientist Award
BLR&D Research Career Scientist Award
批准号:
10293582
负责人:
Carol A. Casey
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-10-01 至 2024-09-30
关键词:
AddressAdmission activityAffectAlcohol abuseAlcoholic Fatty LiverAlcoholic Liver DiseasesAlcoholsAmericanAnimal ModelApoptoticAreaAsialoglycoprotein ReceptorAutophagocytosisAutophagosomeAwardBasic ScienceBiochemicalBiologyBook ChaptersCarcinoembryonic AntigenCellsCellular biologyCessation of lifeChronicClinicalCollaborationsCountryCytolysisDataDefectDestinationsDevelopmentDisease ProgressionEndocytosisEnsureEthanolEthanol MetabolismExocytosisFamilyFibronectinsFunctional disorderGeneral PopulationGoalsGolgi ApparatusGrant ReviewGuanosine Triphosphate PhosphohydrolasesHealthcareHeavy DrinkingHepaticHepatocyteHepatotoxicityImpairmentIn VitroIncidenceInflammatory ResponseInjuryInvestigationJournalsKnowledgeLaboratoriesLeadLigandsLinkLipidsLiverLiver Carbohydrate-Binding ProteinLiver diseasesManuscriptsMediatingMedicalMedical centerMembraneMentorsMilitary PersonnelMissionMonitorMonomeric GTP-Binding ProteinsMorphologyNational Institute on Alcohol Abuse and AlcoholismOrganellesPathogenesisPathway interactionsPatientsPeer ReviewPhysiologicalPlayProcessProgram DevelopmentProtein SecretionProteinsPublishingRecyclingResearchResearch PersonnelRoleScientistSeminalSignal TransductionSocietiesTherapeuticTherapeutic InterventionTimeToxic effectToxinTrainingUnited States National Institutes of HealthVesicleVeteransWorkWorld Healthalcohol consequencesalcohol effectalcohol exposurebasecareerchronic liver diseasedesignexperimental studyfatty liver diseaseimprovedin vivoinsightliver injuryliver transplantationmembermilitary veterannon-alcoholicnon-alcoholic fatty liver diseasenovelpopulation healthproblem drinkerprogramsprotein transportreceptorreceptor mediated endocytosisreceptor recyclingspecial interest groupsymposiumtherapeutic developmenttherapeutic targettherapeutically effectivetherapy developmenttraffickingtrans-Golgi Networkundergraduate studentuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of my current work is to examine how ethanol exposure results in impaired function of the Golgi
apparatus. The Golgi apparatus (also called the Golgi body or Golgi complex) packages proteins into membrane
bound vesicles inside the cell before the vesicles are sent to their destination. As such, this organelle resides at
the intersection of the secretory, lysosomal, and endocytic pathways; it is known to be of particular importance
in processing proteins for secretion. Previous work from our laboratory has identified multiple defects in
endocytosis, protein trafficking, and secretion, after alcohol administration, but we have not until now, examined
a role for altered Golgi function in these processes. Because the incidence of alcoholic liver disease is greater
in the Veteran population and more than half of all medical admissions in VA Medical Centers across the country
are linked to alcohol abuse, we are focusing efforts towards the identification of potential targets to intervene
during the progressive injury which occurs after chronic alcohol administration, and perhaps the Golgi will prove
to be such a target. Of central importance to our study is the role of a small GTPase, Rab3D, which is involved
in exocytosis, secretion and vesicle trafficking. We have shown that Rab3D protein content was significantly
decreased after alcohol administration, and recently we have obtained exciting new preliminary data that ethanol-
impaired Rab3D function plays an important role in Golgi disorganization and fragmentation. The studies
proposed in this application will extend our ongoing investigation of how ethanol alters hepatocyte biology,
specifically in protein processing, to an examination of its role in transport through the Golgi. We provide a
concept as to how alcohol-induced remodeling of Golgi morphology is a significant impairment of post-Golgi
trafficking, and this leads to utilization of trans-Golgi membranes for the formation of autophagosomes. For this
work, we present the following hypothesis: Ethanol exposure contributes to Golgi disorganization via its
fragmentation and autophagy-mediated Golgi membrane lysis, leading to impaired endocytic and
exocytic protein trafficking. Altered distribution and function of the small GTPase Rab3D plays a critical
role in these alterations. To examine our hypothesis, we have proposed three specific aims; in Aim 1 we will
characterize the distribution of Rab3D in vitro and in vivo in liver cells before and after EtOH administration.
Studies proposed for Aim 2 will establish a role for Rab3D in the transport of physiologically relevant hepatic
proteins. These studies will be followed by experiments proposed for Aim 3 where we will determine if EtOH-
induced Golgi disorganization and fragmentation contribute to autophagosome formation and how altered Rab3D
function affects hepatocyte autophagy. Altogether, successful completion of these aims will characterize the
effect of EtOH on Golgi disorganization, and establish a role for altered Rab3D during this process. We will be
able to correlate mechanisms of alcohol-mediated liver cell trafficking impairments with impaired Golgi function
and provide key information that could lead to therapeutic strategies aimed at reducing or eliminating liver injury.
In this work, I am joined by three outstanding co-investigators (Drs. Petrosyan, Thomes and Rasineni), the latter
two are young investigators based at the Omaha VA. I also have collaborative effort with multiple VA
investigators, as outlined in my research plan, and these collaborations have been highly productive. The
exploration of how alcohol impairs function of important organelles such as the Golgi and lipid droplets will
provide new avenues for the development of therapeutic interventions for both alcoholic and non-alcoholic fatty
liver disease. Our contribution is significant since this is a critical step to provide translational knowledge for the
development of therapies for fatty liver disease. Additionally, our findings will also have broader implications for
other hepatic diseases characterized by hepatic injury. With the expertise and collaborations available to my
group, we anticipate that we will be successful in these studies and will be able to contribute to improved
healthcare for Veteran patients by the identification of mechanisms involved in the alcoholic liver injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACORN: Administrative and Planning Core
-
批准号:10526253
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2023
-
负责人:Carol A. Casey
-
依托单位:
Alcohol Center Of Research -- Nebraska (ACORN)
-
批准号:10526252
-
项目类别:
-
资助金额:$156.95万
-
财政年份:2023
-
负责人:Carol A. Casey
-
依托单位:
Downregulation of Rab3D: Critical Role in Golgi Disorganization and the Pathogenesis of Alcoholic Liver Disease
-
批准号:10455408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Carol A. Casey
-
依托单位:
Downregulation of Rab3D: Critical Role in Golgi Disorganization and the Pathogenesis of Alcoholic Liver Disease
-
批准号:9885965
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Carol A. Casey
-
依托单位:
Downregulation of Rab3D: Critical Role in Golgi Disorganization and the Pathogenesis of Alcoholic Liver Disease
-
批准号:10115517
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Carol A. Casey
-
依托单位:
Downregulation of Rab3D: Critical Role in Golgi Disorganization and the Pathogenesis of Alcoholic Liver Disease
-
批准号:10619594
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Carol A. Casey
-
依托单位:
ShEEP Request for a SpectraMax M Series Multi-Mode Microplate Reader
-
批准号:10177680
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Carol A. Casey
-
依托单位:
BLR&D Research Career Scientist Award
-
批准号:10515653
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Carol A. Casey
-
依托单位:
BLR&D Research Career Scientist Award
-
批准号:10047244
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Carol A. Casey
-
依托单位:
Alcohol-altered CEA processing: Role in liver metastases in colorectal cancer
-
批准号:8744678
-
项目类别:
-
资助金额:$15.1万
-
财政年份:2013
-
负责人:Carol A. Casey
-
依托单位:
Alcohol-altered CEA processing: Role in liver metastases in colorectal cancer
-
批准号:8654098
-
项目类别:
-
资助金额:$19.34万
-
财政年份:2013
-
负责人:Carol A. Casey
-
依托单位:
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
-
批准号:10316654
-
项目类别:
-
资助金额:$53.18万
-
财政年份:2011
-
负责人:Carol A. Casey
-
依托单位:
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
-
批准号:9072017
-
项目类别:
-
资助金额:$7.56万
-
财政年份:2011
-
负责人:Carol A. Casey
-
依托单位:
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
-
批准号:10491259
-
项目类别:
-
资助金额:$52.53万
-
财政年份:2011
-
负责人:Carol A. Casey
-
依托单位:
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
-
批准号:8203794
-
项目类别:
-
资助金额:$45.33万
-
财政年份:2011
-
负责人:Carol A. Casey
-
依托单位:
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
-
批准号:8462022
-
项目类别:
-
资助金额:$1.9万
-
财政年份:2011
-
负责人:Carol A. Casey
-
依托单位:
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
-
批准号:8702055
-
项目类别:
-
资助金额:$49.79万
-
财政年份:2011
-
负责人:Carol A. Casey
-
依托单位:
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
-
批准号:9921268
-
项目类别:
-
资助金额:$56.39万
-
财政年份:2011
-
负责人:Carol A. Casey
-
依托单位:
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
-
批准号:10661773
-
项目类别:
-
资助金额:$52.53万
-
财政年份:2011
-
负责人:Carol A. Casey
-
依托单位:
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
-
批准号:9197092
-
项目类别:
-
资助金额:$59.11万
-
财政年份:2011
-
负责人:Carol A. Casey
-
依托单位: